YAP1 and prostate adenocarcinoma: However, reverse phase protein array (RPPA)-based protein profiling of NEK1 and YAP1 in PRAD patients from TCGA datasets revealed upregulation of YAP1 level (Figure 5D), but no change in NEK1 protein level (Figure 5C).